Liver damage and sickle cell disease: genotype relationship.
Marta BortolottiRoberta D'AmbrosioMirella FraquelliPatrizia PedrottiDario ConsonniMargherita Migone De AmicisNatalia ScaramelliniElena Di PierroGiovanna GraziadeiPublished in: Annals of hematology (2020)
Sickle hepatopathy is a severe and not rare complication of sickle cell disease (SCD), showing mainly a cholestatic pattern. So far, no effective approaches to prevent or treat this condition have been recognized. We conducted a single-center observational study in 68 adult sickle cell patients, encompassing 17 with sickle cell anemia (SCA), 38 with sickle cell thalassemia (HbS/β-Thal), and 13 with HbSC disease. The aim of our study was to assess liver damage in the three main forms of SCD, through the evaluation of clinical, laboratory, and imaging findings. In our population, the role of hepatotropic viruses, high BMI, and alcohol consumption in liver damage was ruled out. SCA and HbS/β-Thal patients with lower Hb (p < 0.001), higher HbS (p < 0.001), and frequent vaso-occlusive crises showed functional (GGT values: SCA and HbS/β-Thal vs HbSC p = 0.047 and p = 0.009, respectively) and structural liver abnormalities, defined by abdominal ultrasound and vibration-controlled transient elastography (liver stiffness values: SCA and HbS/β-Thal vs HbSC p 0.022 and p 0.19, respectively), more severe than HbSC patients. Through univariate and multivariate analyses, male sex, SCA genotype, lower HbF, frequent transfusions, increased GGT values, and abnormal liver ultrasound and stiffness were identified as potentially early markers of sickle hepatopathy.
Keyphrases
- sickle cell disease
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- alcohol consumption
- oxidative stress
- magnetic resonance imaging
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- young adults
- physical activity
- mass spectrometry
- high frequency
- photodynamic therapy
- drug induced
- fluorescence imaging